Advocate Health Care sues to keep reimbursement rates secret

Downers Grove, Ill.-based Advocate Health Care has filed a lawsuit to block Palos Heights, Ill.-based Palos Community Hospital from gaining access to Advocate’s trade secrets.

Advertisement

As part of a pending 2013 lawsuit against Advocate and Humana, Palos has requested the managed care agreements held by all 12 Advocate hospitals for a six-year period.

In response, Advocate filed a lawsuit April 11, claiming it was wrongfully sued and should not have to hand over the requested information, including methods for collecting reimbursements from third-party payers and payment rates, according to a Cook County Record report.

“Palos should have never been in a position to request Advocates rate information in discovery…and it is so highly confidential and so valuable as trade secrets that any compelled disclosure would irreparably harm Advocate,” the complaint states.

Advocate is requesting an inunction against Palos to prevent it from gaining access to the information.

More articles on healthcare industry lawsuits:

14 latest healthcare industry lawsuits, settlements
Teen accused of posing as physician offered plea deal
Ex-hospital CFO’s grand theft trial delayed as lawyers work to resolve case

 

At the Becker's 11th Annual IT + Revenue Cycle Conference: The Future of AI & Digital Health, taking place September 14–17 in Chicago, healthcare executives and digital leaders from across the country will come together to explore how AI, interoperability, cybersecurity, and revenue cycle innovation are transforming care delivery, strengthening financial performance, and driving the next era of digital health. Apply for complimentary registration now.

Download Whitepaper

The cost-saving opportunity most health systems overlook

Many hospitals and health systems scrutinize staffing, service lines, and payer contracts for savings. Fewer look at one of their largest assets: real estate.…

Advertisement

Next Up in Legal & Regulatory Issues

Advertisement

Comments are closed.